Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-19-027931)

Filing Details

Accession Number:: 0001127602-19-027931
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-09-04 18:08:56
Reporting Period:: 2019-09-04

Accepted Time:: 2019-09-04 18:08:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
318154	Amgen Inc	AMGN	Biological Products, (No Disgnostic Substances) (2836)	953540776

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1216519	D Ronald Sugar	One Amgen Center Drive Thousand Oaks CA 91320-1799		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-09-04	2,000	$54.71	16,336	No	4	M	Direct
Common Stock	Disposition	2019-09-04	2,000	$206.70	14,336	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Nqso (Right to Buy)	Disposition	2019-09-04	2,000	$0.00	2,000	$54.71

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
4,000	2011-08-03	2020-08-03	No	4	M	Direct

Footnotes

The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1.
These shares include 1,519 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.